Patent 9688758 was granted and assigned to Genentech on June, 2017 by the United States Patent and Trademark Office.
The invention provides engineered heteromultimeric protein complexes constructed using one, two, or three tethers and methods for making, using, and purifying such complexes, such as antibodies with different binding properties.